April 23, 2003
Recall Update: Boehringer Ingelheim Chemicals Glycopyrrolate USP Recall is Complete
The Food and Drug
Administration (FDA) released the following information.
Glycopyrrolate USP, G136, bulk powder, drum, Rx only, Caution: For Manufacturing, Processing, or Repacking. Recall # D-196-3.
Boehringer Ingelheim Chemicals, Inc, Petersburg, VA, by letter on October 25, 2002. Firm initiated recall is complete.
Contamination; bulk drug contains glass.
VOLUME OF PRODUCT IN COMMERCE
GA and Canada.